US Patent Issued on July 14 for "Peptide, and cell fusion agent and pharmaceutical composition for cancer therapy containing said peptide" (Japanese Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,866, issued on July 14.

"Peptide, and cell fusion agent and pharmaceutical composition for cancer therapy containing said peptide" was invented by Michiko Koga (Shizuoka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An object of the present invention is to provide an efficient method of cell fusion, and to provide a method of killing cancer cells by cell fusion. The object can be solved by (1) a polypeptide comprising an amino acid sequence selected from the group consisting of the amino acid sequences of SEQ ID NOs: 1 to 8, or (2) a polypeptide comprising an amino acid sequence, in which 1 to 4 amino acids are deleted, substituted, inserted...